CY1109283T1 - Παραγωγα βαριολινης ως αντικαρκινικα μεσα - Google Patents
Παραγωγα βαριολινης ως αντικαρκινικα μεσαInfo
- Publication number
- CY1109283T1 CY1109283T1 CY20091100849T CY091100849T CY1109283T1 CY 1109283 T1 CY1109283 T1 CY 1109283T1 CY 20091100849 T CY20091100849 T CY 20091100849T CY 091100849 T CY091100849 T CY 091100849T CY 1109283 T1 CY1109283 T1 CY 1109283T1
- Authority
- CY
- Cyprus
- Prior art keywords
- group
- substituted
- unsubstituted
- unsubstituted aryl
- bariolin
- Prior art date
Links
- 229930186114 Variolin Natural products 0.000 title 1
- 230000001093 anti-cancer Effects 0.000 title 1
- 125000003118 aryl group Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000004641 (C1-C12) haloalkyl group Chemical group 0.000 abstract 2
- 125000006710 (C2-C12) alkenyl group Chemical group 0.000 abstract 2
- 125000006711 (C2-C12) alkynyl group Chemical group 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 230000037361 pathway Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Η εφεύρεση παρέχει παράγωγα βαριολίνης του τύπου (I), όπου: R1 και R2 επιλέγεται έκαστη ανεξαρτήτως από την ομάδα που αποτελείται από Η, OH, OR, SH, SR, SOR, SO2R, ΝO2, ΝΗ2, NHR, N(R)2, NHCOR, N(COR)2, NHSO2R, CN, αλογόνο, C(=O)H, C(=O)R, CO2H, CO2R, C1-C12αλκύλιο, C1-C12αλογοναλκύλιο, C2-C12αλκενύλιο, C2-C12αλκυνύλιο, υποκατεστημένο ή μη υποκατεστημένο αρύλιο, υποκατεστημένο ή μη υποκατεστημένο αραλκύλιο και υποκατεστημένη ή μη υποκατεστημένη ετεροαρωματική ομάδα· και R3 επιλέγεται από την ομάδα που αποτελείται από Η, ΟΗ, και OMe- όπου η ομάδα R, ή έκαστη ομάδα R, επιλέγεται ανεξαρτήτως από την ομάδα που αποτελείται από ΟΗ, C1-C12αλκύλιο, C1-C12αλογοναλκύλιο, C2-C12-αλκενύλιο, C2-C12αλκυνύλιο, υποκατεστημένο ή μη υποκατεστημένο αρύλιο, υποκατεστημένο ή μη υποκατεστημένο αραλκύλιο, υποκατεστημένο ή μη υποκατεστημένο αρυλαλκενύλιο και υποκατεστημένη ή μη υποκατεστημένη ετεροαρωματική ομάδα, και όπου η ομάδα R1, R2 ή R3 είναι ομάδα του τύπου N(R)2 ή N(COR)2, έκαστη των ομάδων R μπορεί να είναι η ίδια ή να διαφέρει, ή οι δύο ομάδες R, μαζί με το άτομο αζώτου στο οποίο είναι προσαρτημένες, μπορούν να σχηματίζουν 5-14μελή ετεροκυκλικό δακτύλιο. Οι ενώσεις αυτές εμφανίζουν δραστικότητα έναντι μίας σειράς κυτταρικών γραμμών καρκίνου θηλαστικών. Επίσης παρουσιάζονται νέες συνθετικές πορείες για νέες και γνωστές ενώσεις βαριολίνης, μαζί με πρωτότυπα ενδιάμεσα. Επίσης περιγράφεται νέα αντινεαπλασιακή δραστικότητα γνωστών ενώσεων βαριολίνης.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0017055A GB0017055D0 (en) | 2000-07-11 | 2000-07-11 | Synthesis |
GB0030689A GB0030689D0 (en) | 2000-12-15 | 2000-12-15 | Synthesis |
EP01949663A EP1299388B1 (en) | 2000-07-11 | 2001-07-11 | Variolin derivatives as anti-cancer agents |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1109283T1 true CY1109283T1 (el) | 2014-07-02 |
Family
ID=26244637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20091100849T CY1109283T1 (el) | 2000-07-11 | 2009-08-11 | Παραγωγα βαριολινης ως αντικαρκινικα μεσα |
Country Status (20)
Country | Link |
---|---|
US (1) | US7320981B2 (el) |
EP (1) | EP1299388B1 (el) |
JP (1) | JP2004502773A (el) |
KR (1) | KR100886161B1 (el) |
CN (1) | CN1324028C (el) |
AT (1) | ATE431349T1 (el) |
AU (3) | AU2001270783B2 (el) |
BR (1) | BR0112413A (el) |
CA (1) | CA2414200C (el) |
CY (1) | CY1109283T1 (el) |
DE (1) | DE60138707D1 (el) |
DK (1) | DK1299388T3 (el) |
ES (1) | ES2327210T3 (el) |
IL (2) | IL153682A0 (el) |
MX (1) | MXPA03000341A (el) |
NZ (1) | NZ523491A (el) |
PT (1) | PT1299388E (el) |
RU (1) | RU2299884C2 (el) |
SI (1) | SI1299388T1 (el) |
WO (1) | WO2002004447A1 (el) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0019117D0 (en) | 2000-08-03 | 2000-09-27 | Univ Barcelona | Derivatives of variolin B |
GB0116966D0 (en) * | 2001-07-11 | 2001-09-05 | Pharma Mar Sa | Anittumoral compounds |
DE10260235B4 (de) | 2002-12-20 | 2010-10-28 | Infineon Technologies Ag | Verfahren zum Strukturieren einer Resistschicht und Negativ-Resistschicht |
US7902192B2 (en) | 2003-05-15 | 2011-03-08 | Arqule, Inc. | Inhibitors of P38 and methods of using the same |
US7829560B2 (en) | 2004-07-08 | 2010-11-09 | Arqule, Inc. | 1,4-disubstituted naphthalenes as inhibitors of P38 MAP kinase |
EP1809636A1 (en) | 2004-10-19 | 2007-07-25 | Arqule, Inc. | Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase |
EP1666467A1 (en) * | 2004-11-08 | 2006-06-07 | Evotec AG | 11Beta-HSD1 Inhibitors |
WO2006075591A1 (ja) * | 2005-01-12 | 2006-07-20 | Kuraray Co., Ltd. | 樹脂組成物及びそれからなるフィルム |
ATE469151T1 (de) * | 2005-05-16 | 2010-06-15 | Irm Llc | Pyrrolopyridinderivate als proteinkinaseinhibitoren |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0019117D0 (en) * | 2000-08-03 | 2000-09-27 | Univ Barcelona | Derivatives of variolin B |
GB0116966D0 (en) | 2001-07-11 | 2001-09-05 | Pharma Mar Sa | Anittumoral compounds |
-
2001
- 2001-07-11 DK DK01949663T patent/DK1299388T3/da active
- 2001-07-11 EP EP01949663A patent/EP1299388B1/en not_active Expired - Lifetime
- 2001-07-11 PT PT01949663T patent/PT1299388E/pt unknown
- 2001-07-11 RU RU2003103856/04A patent/RU2299884C2/ru not_active IP Right Cessation
- 2001-07-11 US US10/332,562 patent/US7320981B2/en not_active Expired - Fee Related
- 2001-07-11 AT AT01949663T patent/ATE431349T1/de not_active IP Right Cessation
- 2001-07-11 BR BR0112413-7A patent/BR0112413A/pt not_active Application Discontinuation
- 2001-07-11 IL IL15368201A patent/IL153682A0/xx unknown
- 2001-07-11 CA CA2414200A patent/CA2414200C/en not_active Expired - Fee Related
- 2001-07-11 AU AU2001270783A patent/AU2001270783B2/en not_active Revoked
- 2001-07-11 AU AU7078301A patent/AU7078301A/xx active Pending
- 2001-07-11 DE DE60138707T patent/DE60138707D1/de not_active Expired - Lifetime
- 2001-07-11 JP JP2002509312A patent/JP2004502773A/ja active Pending
- 2001-07-11 CN CNB018153666A patent/CN1324028C/zh not_active Expired - Fee Related
- 2001-07-11 NZ NZ523491A patent/NZ523491A/en unknown
- 2001-07-11 SI SI200130927T patent/SI1299388T1/sl unknown
- 2001-07-11 MX MXPA03000341A patent/MXPA03000341A/es active IP Right Grant
- 2001-07-11 ES ES01949663T patent/ES2327210T3/es not_active Expired - Lifetime
- 2001-07-11 WO PCT/GB2001/003111 patent/WO2002004447A1/en active IP Right Grant
- 2001-07-11 KR KR1020027018072A patent/KR100886161B1/ko not_active IP Right Cessation
-
2002
- 2002-12-26 IL IL153682A patent/IL153682A/en not_active IP Right Cessation
-
2006
- 2006-09-13 AU AU2006213946A patent/AU2006213946B2/en not_active Ceased
-
2009
- 2009-08-11 CY CY20091100849T patent/CY1109283T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
SI1299388T1 (sl) | 2009-12-31 |
KR20030017581A (ko) | 2003-03-03 |
US7320981B2 (en) | 2008-01-22 |
AU2001270783B2 (en) | 2006-06-15 |
DK1299388T3 (da) | 2009-08-31 |
IL153682A (en) | 2010-05-31 |
AU2006213946A1 (en) | 2006-10-05 |
US20050014778A1 (en) | 2005-01-20 |
ES2327210T3 (es) | 2009-10-27 |
EP1299388B1 (en) | 2009-05-13 |
ATE431349T1 (de) | 2009-05-15 |
CA2414200C (en) | 2010-05-04 |
KR100886161B1 (ko) | 2009-02-27 |
RU2299884C2 (ru) | 2007-05-27 |
CN1324028C (zh) | 2007-07-04 |
IL153682A0 (en) | 2003-07-06 |
CN1630658A (zh) | 2005-06-22 |
DE60138707D1 (de) | 2009-06-25 |
CA2414200A1 (en) | 2002-01-17 |
AU7078301A (en) | 2002-01-21 |
NZ523491A (en) | 2004-06-25 |
EP1299388A1 (en) | 2003-04-09 |
PT1299388E (pt) | 2009-08-13 |
BR0112413A (pt) | 2003-05-27 |
WO2002004447A1 (en) | 2002-01-17 |
JP2004502773A (ja) | 2004-01-29 |
MXPA03000341A (es) | 2004-04-05 |
AU2006213946B2 (en) | 2008-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1109283T1 (el) | Παραγωγα βαριολινης ως αντικαρκινικα μεσα | |
CY1108313T1 (el) | Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6 | |
CY1120189T1 (el) | Λιπιδια, συμπλοκα λιπιδιων και χρηση εξ' αυτων | |
CY1107830T1 (el) | Αντικαρκινικα αναλογα | |
ATE303063T1 (de) | Synthetische analoge des ecteinascidin-743 | |
CY1109345T1 (el) | ΠΑΡΑΓΩΓΑ ΥΠΟΚΑΤΕΣΤΗΜΕΝΗΣ 8-ΥΠΕΡΦΘΟΡΟΑΛΚΥΛΟ-6,7,8,9-ΤΕΤΡΑΫΔΡΟΠΥΡΙΜΙΔΟ (1,2-a) ΠΥΡΙΜΙΔΙΝ-4-ΟΝΗΣ | |
DE69418704D1 (de) | Anthranilsäure derivate | |
MA18694A1 (fr) | Nouveaux derives de piperidinyl alkyl-quinazoline | |
DK1489090T3 (da) | Hidtil ukendte pseudoerythromycinderivater | |
ATE88714T1 (de) | 2'-desoxy-5-fluoruridinderivate. | |
CY1113359T1 (el) | Αντι-νεοπλασιακα παραγωγα του et-743 | |
DK1022276T3 (da) | Epoxysuccinamidderivater | |
DE60237652D1 (de) | Variolinderivate und ihre Verwendung als Cytostatika | |
MXPA02012121A (es) | Compuestos antitumorales. | |
NO20051037L (no) | Totalsyntese av myriaporoner |